HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nadia Peragine Selected Research

Chlorambucil (Leukeran)

5/2014Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nadia Peragine Research Topics

Disease

13B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 06/2007
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2021 - 02/2007
3Neoplasms (Cancer)
01/2021 - 07/2010
2Disease Progression
01/2012 - 08/2008
1Infertility (Sterility)
07/2015
1Philadelphia Chromosome
04/2011
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
04/2011
1Leukemia
04/2011
1Spontaneous Remission
07/2009
1Pathologic Complete Response
02/2007

Drug/Important Bio-Agent (IBA)

4Biological ProductsIBA
07/2014 - 07/2009
3ibrutinibIBA
01/2022 - 10/2020
2Phosphotransferases (Kinase)IBA
01/2021 - 04/2011
2Rituximab (Mabthera)FDA Link
10/2020 - 05/2014
2Immunoglobulin M (IgM)IBA
04/2015 - 08/2008
2MicroRNAs (MicroRNA)IBA
04/2015 - 06/2007
2Pharmaceutical PreparationsIBA
11/2013 - 04/2011
2Protein Kinases (Protein Kinase)IBA
07/2010 - 06/2010
1blinatumomabIBA
12/2021
1Dasatinib (BMS 354825)FDA Link
12/2021
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2021
1MTOR InhibitorsIBA
01/2016
1RNA (Ribonucleic Acid)IBA
01/2016
1EndotoxinsIBA
07/2015
1Neutralizing AntibodiesIBA
07/2014
1LigandsIBA
07/2014
1Natural Killer Cell ReceptorsIBA
07/2014
1Chlorambucil (Leukeran)FDA Link
05/2014
1NucleotidesIBA
11/2013
1nutlin 3IBA
11/2013
1Immunoglobulin D (IgD)IBA
04/2013
1Proteins (Proteins, Gene)FDA Link
01/2012
1Immunoglobulin Variable RegionIBA
04/2011
1Tyrosine (L-Tyrosine)FDA Link
04/2011
1Imatinib Mesylate (Gleevec)FDA Link
04/2011
1Protein Kinase InhibitorsIBA
06/2010
1Interleukin-4 (Interleukin 4)IBA
07/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2009

Therapy/Procedure

3Therapeutics
01/2019 - 02/2007
1Ligation
08/2008